Related references
Note: Only part of the references are listed.Cerebellar modulation of the reward circuitry and social behavior
Flaria Carta et al.
SCIENCE (2019)
Assessment of Instruments for Measurement of Delirium Severity A Systematic Review
Richard N. Jones et al.
JAMA INTERNAL MEDICINE (2019)
Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study
Geoffrey E. Noller et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2018)
Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomes
Thomas Kingsley Brown et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2018)
Ibogaine Detoxification Transitions Opioid and Cocaine Abusers Between Dependence and Abstinence: Clinical Observations and Treatment Outcomes
Deborah C. Mash et al.
FRONTIERS IN PHARMACOLOGY (2018)
Hallucinogen Persisting Perception Disorder After Ibogaine Treatment for Opioid Dependence
Thomas Knuijver et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2018)
Pharmacologic Treatment of Opioid Use Disorder: a Review of Pharmacotherapy, Adjuncts, and Toxicity
Michael S. Toce et al.
JOURNAL OF MEDICAL TOXICOLOGY (2018)
Changes in Withdrawal and Craving Scores in Participants Undergoing Opioid Detoxification Utilizing Ibogaine
Benjamin J. Malcolm et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2018)
Validation of the Prognostic Utility of the Electrocardiogram for Acute Drug Overdose
Alex F. Manini et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Examination of the Phenomenology of the Ibogaine Treatment Experience: Role of Altered States of Consciousness and Psychedelic Experiences
Annamarie Heink et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2017)
Ibogaine for treating drug dependence. What is a safe dose?
L. J. Schep et al.
DRUG AND ALCOHOL DEPENDENCE (2016)
Ibogaine and addiction in the animal model, a systematic review and meta-analysis
M. Belgers et al.
TRANSLATIONAL PSYCHIATRY (2016)
Influence of CYP2D6 Activity on the Pharmacokinetics and Pharmacodynamics of a Single 20 mg Dose of Ibogaine in Healthy Volunteers
Paul Glue et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2015)
The Anti-Addiction Drug Ibogaine and the Heart: A Delicate Relation
Xaver Koenig et al.
MOLECULES (2015)
Ascending-Dose Study of Noribogaine in Healthy Volunteers: Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability
Paul Glue et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Mania Following Use of Ibogaine: A Case Series
Cole J. Marta et al.
AMERICAN JOURNAL ON ADDICTIONS (2015)
Anti-addiction drug ibogaine inhibits hERG channels: a cardiac arrhythmia risk
Xaver Koenig et al.
ADDICTION BIOLOGY (2014)
Treating drug dependence with the aid of ibogaine: A retrospective study
Eduardo Ekman Schenberg et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
Metoclopramide is metabolized by CYP2D6 and is a reversible inhibitor, but not inactivator, of CYP2D6
Mara R. Livezey et al.
XENOBIOTICA (2014)
The Measurement of the QT Interval
Pieter G. Postema et al.
CURRENT CARDIOLOGY REVIEWS (2014)
Mechanism of hERG Channel Block by the Psychoactive Indole Alkaloid Ibogaine
Patrick Thurner et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Anti-addiction drug ibogaine inhibits voltage-gated ionic currents: A study to assess the drug's cardiac ion channel profile
Xaver Koenig et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Fatalities Temporally Associated with the Ingestion of Ibogaine
Kenneth R. Alper et al.
JOURNAL OF FORENSIC SCIENCES (2012)
Responsiveness of different rating instruments in spinocerebellar ataxia patients
T. Schmitz-Huebsch et al.
NEUROLOGY (2010)
Metoclopramide as a Possible Cause of Prolonged QT Syndrome and Torsade de Pointes in a Patient With Heart Failure and Renal Insufficiency
Sultan M. Siddique et al.
ANNALS OF INTERNAL MEDICINE (2009)
Ibogaine, an anti-addictive drug: pharmacology and time to go further in development. A narrative review
R. Maculaitis et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2008)
Usefulness of the scale for assessment and rating of ataxia (SARA)
Ichiro Yabe et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Reliability and validity of the scale for the assessment and rating of ataxia: A study in 64 ataxia patients
Anja Weyer et al.
MOVEMENT DISORDERS (2007)
Scale for the assessment and rating of ataxia -: Development of a new clinical scale
T. Schmitz-Huebsch et al.
NEUROLOGY (2006)
The addiction severity index at 25: Origins, contributions and transitions
AT McLellan et al.
AMERICAN JOURNAL ON ADDICTIONS (2006)
QT interval: How to measure it and what is normal
I Goldenberg et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2006)
The effect of metoclopramide on QT dynamicity: double-blind, placebo-controlled, cross-over study in healthy male volunteers
E Ellidokuz et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Share Paper
